semaglutide oral cardiovascular indication 2025 news outcomes align more closely with attained dose than achieved weight loss SOUL trial shows oral semaglutide
Description
You can look it up
Adding to its convenience, the FDA approved the Wegovy pill, an oral semaglutide, in December 2025 for those who prefer a non-injection option
Regular monitoring of blood sugar and kidney function is advised
References Do, D., Lee, T., Peasah, S
Researchers note that the consistency of effects across multiple substances and outcomes provides a strong rationale for dedicated clinical trials
Reflux may be more noticeable after large meals, high-fat or spicy foods, carbonated drinks, or lying down soon after eating
